Kyowa Hakko Kirin | 4151 - Sales Revenues


Kyowa Hakko Kirin reported JPY121.3B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Astellas Pharma JPY 640.91B 102.98B Jun/2026
Chugai Pharma JPY 404.7B 63.1B Sep/2026
Daiichi Sankyo JPY 592.49B 17.75B Sep/2026
Eisai JPY 234.33B 28.9B Jun/2026
Kyowa Hakko Kirin JPY 121.3B 23.86B Sep/2026
M3 JPY 90.11B 3.14B Jun/2026
Otsuka Holdings JPY 710.05B 8B Sep/2026
Shionogi JPY 187.07B 23.76B Sep/2026
Sumitomo Dainippon JPY 137B 7.5B Sep/2026
Takeda JPY 1.19T 32.9B Sep/2026
Terumo JPY 311.81B 11.49B Jun/2026